Ouyang Yi-Bing, Xu Lijun, Liu Siwei, Giffard Rona G
Department of Anesthesia, Stanford University School of Medicine, 300 Pasteur Drive, S272A and S290, Stanford, CA, 94305-5117, USA,
Adv Neurobiol. 2014;11:171-88. doi: 10.1007/978-3-319-08894-5_9.
Astrocytes have been shown to protect neurons from delayed neuronal death and increase their survival in cerebral ischemia. One of the main mechanisms of astrocyte protection is rapid removal of excess glutamate from synaptic sites by astrocytic plasma membrane glutamate transporters such as GLT-1/EAAT-2, reducing excitotoxicity. Astrocytic mitochondrial function is essential for normal GLT-1 function. Manipulating astrocytic mitochondrial and GLT-1 function is thus an important strategy to enhance neuronal survival and improve outcome following cerebral ischemia. Increasing evidence supports the involvement of microRNAs (miRNA), some of them being astrocyte-enriched, in the regulation of cerebral ischemia. This chapter will first update the information about astrocytes, GLT-1, astrocytic mitochondria, and delayed neuronal death. Then we will focus on two recently reported astrocyte-enriched miRNAs (miR-181 and miR-29 families), their effects on astrocytic mitochondria and GLT-1 as well as on outcome after cerebral ischemia.
星形胶质细胞已被证明可保护神经元免受迟发性神经元死亡,并增加其在脑缺血中的存活率。星形胶质细胞保护的主要机制之一是通过星形胶质细胞质膜谷氨酸转运体(如GLT-1/EAAT-2)快速从突触部位清除过量谷氨酸,从而降低兴奋性毒性。星形胶质细胞的线粒体功能对于正常的GLT-1功能至关重要。因此,操纵星形胶质细胞的线粒体和GLT-1功能是提高神经元存活率和改善脑缺血后预后的重要策略。越来越多的证据支持微小RNA(miRNA)参与脑缺血的调节,其中一些在星形胶质细胞中高度富集。本章将首先更新有关星形胶质细胞、GLT-1、星形胶质细胞线粒体和迟发性神经元死亡的信息。然后,我们将重点关注最近报道的两种在星形胶质细胞中高度富集的miRNA(miR-181和miR-29家族),它们对星形胶质细胞线粒体和GLT-1的影响以及对脑缺血后预后的影响。